ATM expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62447832963153E-12 |
Normal-vs-Stage2 |
1.08069999948945E-07 |
Normal-vs-Stage3 |
1.7779999694767E-11 |
Normal-vs-Stage4 |
3.25310001159096E-09 |
Stage1-vs-Stage2 |
2.282400E-01 |
Stage1-vs-Stage3 |
4.217200E-01 |
Stage1-vs-Stage4 |
1.277950E-01 |
Stage2-vs-Stage3 |
1.410810E-01 |
Stage2-vs-Stage4 |
6.094100E-02 |
Stage3-vs-Stage4 |
5.449400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
1.83850000001762E-06 |
Normal-vs-Asian |
1.03169999998709E-06 |
Caucasian-vs-AfricanAmerican |
2.315200E-01 |
Caucasian-vs-Asian |
7.766200E-01 |
AfricanAmerican-vs-Asian |
3.817400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
<1E-12 |
Male-vs-Female |
1.781590E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.786470E-02 |
Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
1.124590E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.623900E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.485600E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.048840E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.562240E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.209400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.034000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.403400E-04 |
Normal-vs-Grade 2 |
1.62458935193399E-12 |
Normal-vs-Grade 3 |
1.11022302462516E-16 |
Normal-vs-Grade 4 |
1.98309999999147E-06 |
Grade 1-vs-Grade 2 |
1.949830E-01 |
Grade 1-vs-Grade 3 |
2.925900E-02 |
Grade 1-vs-Grade 4 |
1.895810E-02 |
Grade 2-vs-Grade 3 |
8.882500E-02 |
Grade 2-vs-Grade 4 |
3.217000E-04 |
Grade 3-vs-Grade 4 |
2.173600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62458935193399E-12 |
Normal-vs-ccB subtype |
4.93899998676994E-09 |
ccA subtype-vs-ccB subtype |
1.76180003919058E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62436730732907E-12 |
Normal-vs-N1 |
1.714310E-02 |
N0-vs-N1 |
2.644800E-01 |
|
|